Found: 8
Select item for more details and to access through your institution.
A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 6, p. 804, doi. 10.1111/bjh.13500
- By:
- Publication type:
- Article
Intensification treatment based on early FDG- PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 327, doi. 10.1111/bjh.13036
- By:
- Publication type:
- Article
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2766, doi. 10.1002/cam4.1217
- By:
- Publication type:
- Article
Thrombopoietin receptor agonist switch in adult primary immune thrombocytopenia patients: A retrospective collaborative survey involving 4 Spanish centres.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 4, p. 372, doi. 10.1111/ejh.12932
- By:
- Publication type:
- Article
Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 3, p. 281, doi. 10.1111/j.1600-0609.2011.01644.x
- By:
- Publication type:
- Article
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL–TAMO Study Group.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 3, p. 227, doi. 10.1111/j.1600-0609.2007.01020.x
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
- By:
- Publication type:
- Article
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0283-8
- By:
- Publication type:
- Article